277 related articles for article (PubMed ID: 2566675)
41. Endothelium-dependent relaxation of rat aorta by butein, a novel cyclic AMP-specific phosphodiesterase inhibitor.
Yu SM; Cheng ZJ; Kuo SC
Eur J Pharmacol; 1995 Jun; 280(1):69-77. PubMed ID: 7498256
[TBL] [Abstract][Full Text] [Related]
42. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells.
Papapetropoulos A; Go CY; Murad F; Catravas JD
Br J Pharmacol; 1996 Jan; 117(1):147-55. PubMed ID: 8825356
[TBL] [Abstract][Full Text] [Related]
43. Prolonged exposure to catecholamines enhances sensitivity of smooth muscle relaxation induced by sodium nitroprusside and atriopeptin.
Hu ZW; Honda K; Murad F; Hoffman BB
J Pharmacol Exp Ther; 1992 Feb; 260(2):756-61. PubMed ID: 1346644
[TBL] [Abstract][Full Text] [Related]
44. Contribution of phosphodiesterase isoenzymes and cyclic nucleotide efflux to the regulation of cyclic GMP levels in aortic smooth muscle cells.
Mercapide J; Santiago E; Alberdi E; Martinez-Irujo JJ
Biochem Pharmacol; 1999 Nov; 58(10):1675-83. PubMed ID: 10535760
[TBL] [Abstract][Full Text] [Related]
45. Aging and chronic hypertension decrease expression of rat aortic soluble guanylyl cyclase.
Klöss S; Bouloumié A; Mülsch A
Hypertension; 2000 Jan; 35(1 Pt 1):43-7. PubMed ID: 10642273
[TBL] [Abstract][Full Text] [Related]
46. Increases in flow reduce the release of endothelium-derived relaxing factor in the aorta of normotensive and spontaneously hypertensive rats.
Hoeffner U; Vanhoutte PM
Am J Hypertens; 1989 Oct; 2(10):762-7. PubMed ID: 2803671
[TBL] [Abstract][Full Text] [Related]
47. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide.
Thusu KG; Morin FC; Russell JA; Steinhorn RH
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302
[TBL] [Abstract][Full Text] [Related]
48. Endothelium-derived relaxing factor, hypertension and chronic parathyroidectomy in spontaneously hypertensive and Wistar-Kyoto rats.
Boulebda N; Van Overloop B; Gairard A
Clin Exp Pharmacol Physiol; 1993 Dec; 20(12):773-85. PubMed ID: 8306520
[TBL] [Abstract][Full Text] [Related]
49. Induction of guinea pig airway hyperresponsiveness by inactivation of guanylate cyclase.
Sadeghi-Hashjin G; Folkerts G; Henricks PA; Van de Loo PG; Van der Linde HJ; Dik IE; Nijkamp FP
Eur J Pharmacol; 1996 Apr; 302(1-3):109-15. PubMed ID: 8790998
[TBL] [Abstract][Full Text] [Related]
50. Actions of 3-morpholinosydnonimin (SIN-1) on rabbit isolated penile erectile tissue.
Holmquist F; Fridstrand M; Hedlund H; Andersson KE
J Urol; 1993 Oct; 150(4):1310-5. PubMed ID: 8396690
[TBL] [Abstract][Full Text] [Related]
51. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
Hussain MB; Hobbs AJ; MacAllister RJ
Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
[TBL] [Abstract][Full Text] [Related]
52. Blunted cGMP response to ANF in vascular smooth muscle cells of SHR.
Nakamura M; Nakamura A; Fine B; Aviv A
Am J Physiol; 1988 Nov; 255(5 Pt 1):C573-80. PubMed ID: 2847533
[TBL] [Abstract][Full Text] [Related]
53. Zaprinast increases cyclic GMP levels in plasma and in aortic tissue of rats.
Dundore RL; Clas DM; Wheeler LT; Habeeb PG; Bode DC; Buchholz RA; Silver PJ; Pagani ED
Eur J Pharmacol; 1993 Nov; 249(3):293-7. PubMed ID: 8287916
[TBL] [Abstract][Full Text] [Related]
54. Augmentation of the natriuretic activity of exogenous and endogenous atriopeptin in rats by inhibition of guanosine 3',5'-cyclic monophosphate degradation.
Wilkins MR; Settle SL; Needleman P
J Clin Invest; 1990 Apr; 85(4):1274-9. PubMed ID: 2156897
[TBL] [Abstract][Full Text] [Related]
55. Pulmonary effects of type V cyclic GMP specific phosphodiesterase inhibition in the anaesthetized guinea-pig.
Turner NC; Dolan JS; Grimsditch D; Lamb J; Worby A; Murray KJ; Coates WJ; Warrington BH
Br J Pharmacol; 1994 Apr; 111(4):1198-204. PubMed ID: 8032606
[TBL] [Abstract][Full Text] [Related]
56. Sildenafil, a novel inhibitor of phosphodiesterase type 5 in human corpus cavernosum smooth muscle cells.
Moreland RB; Goldstein I; Traish A
Life Sci; 1998; 62(20):PL 309-18. PubMed ID: 9600334
[TBL] [Abstract][Full Text] [Related]
57. Vasodilator dysfunction in aged spontaneously hypertensive rats: changes in NO synthase III and soluble guanylyl cyclase expression, and in superoxide anion production.
Bauersachs J; Bouloumié A; Mülsch A; Wiemer G; Fleming I; Busse R
Cardiovasc Res; 1998 Mar; 37(3):772-9. PubMed ID: 9659462
[TBL] [Abstract][Full Text] [Related]
58. Depressor and natriuretic effects of M&B 22,948, a guanosine cyclic 3',5'-monophosphate-selective phosphodiesterase inhibitor.
McMahon EG; Palomo MA; Mehta P; Olins GM
J Pharmacol Exp Ther; 1989 Dec; 251(3):1000-5. PubMed ID: 2557409
[TBL] [Abstract][Full Text] [Related]
59. Reduction of the soluble cyclic GMP vasorelaxing system in the vascular wall of stroke-prone spontaneously hypertensive rats: effect of the alpha1 -receptor blocker doxazosin.
López-Farré A; Rodriguez-Feo JA; García-Colis E; Gomez J; López-Blaya A; Fortes J; de Andrés R; Rico L; Casado S
J Hypertens; 2002 Mar; 20(3):463-70. PubMed ID: 11875314
[TBL] [Abstract][Full Text] [Related]
60. Impaired relaxing response to isoprenaline in isolated thoracic aorta of nephrotic rats: decrease in release of EDRF from endothelial cells.
Ito M; Yamamoto I; Naruse A; Suzuki Y; Satake N; Shibata S
J Cardiovasc Pharmacol; 1997 Feb; 29(2):232-9. PubMed ID: 9057073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
